The influence of program acceptability on the effectiveness of public health policy: A study of directly observed therapy for tuberculosis

American Journal of Public Health

Volumn 88, Issue 3, 1998, Pages 442-445

  Heymann, S Jody ^a   Sell, Randall ^b   Brewer, Timothy F ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Columbia School of Medicine ^*  (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG RESISTANCE; EPIDEMIC; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL DECISION MAKING; PUBLIC HEALTH; TUBERCULOSIS;

EID: 0031977694     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.88.3.442     Document Type: Article

References (23)

1. Rieder HL, Cauthen GM, Comstock GW, Snider DE. Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989;11:79-98.
2. Centers for Disease Control and Prevention. Expanded tuberculosis surveillance and tuberculosis morbidity - United States, 1993. MMWR Morb Mortal Wkly Rep. 1994; 43:361-366.
3. Centers for Disease Control and Prevention. Nosocomial transmission of multidrug-resistant TB among HIV-infected persons -Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991;40:585.
4. Frieden TR, Sterling T, Pablos-Mendez A. Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993;328:521-526.
5. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug resistant tuberculosis in the United States. JAMA. 1994;271: 665-671.
6. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1993;42(RR-7):1-8.
7. WHO Report on the Tuberculosis Epidemic, 1995. Geneva, Switzerland: World Health Organization; 1995:1-28. WHO/TB/95.183.
8. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA. 1995;274:945-951.
9. Curtis R, Friedman SR, Neaigus A, Jose B, Goldstein M, Des Jarlais DC. Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep. 1994;109:319-327.
10. Blower SM, McLean AR. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science. 1994;265:1451-1454.
11. Otten MW, Zaidi AA, Wroten JE, Witte JJ, Peterman TA. Changes in sexually transmitted disease rates after HIV testing and posttest counseling, Miami, 1988 to 1989. Am J Public Health. 1993;83:529-533.
12. Combs DL, O'Brien RJ, Geiter LJ. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. Ann Intern Med. 1990;112:397-406.
13. McDonald RJ, Memon AM, Reichman LB. Successful supervised ambulatory management of tuberculosis treatment failures. Ann Intern Med. 1982;96:297-302.
14. Farmer P, Robin S, Ramilus SL, Kim JY. Tuberculosis, poverty, and "compliance": lessons from rural Haiti. Semin Respir Infect. 1991;6:254-260.
15. National Tuberculosis Institute, Bangalore. Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull World Health Organ. 1974;51:473-488.
16. Dutt AK, Moers D, Stead WW. Short-course chemotherapy for tuberculosis with twice-weekly isoniazid and rifampin: community physicans' seven year experience with mainly outpatients. Am J Med. 1984;77:233-242.
17. Centers for Disease Control and Prevention. National action plan to combat multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 1992;41(RR-11): 1-30.
18. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 patients with pulmonary turberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993;328:527-532.
19. Telzak EE, Sepkowitz K, Alpert P, et al. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med. 1995;333: 907-911.
20. Burwen D, Bloch A, Griffin I, Ciesielski C, Stern H, Onorato I. National trends in IDS cases with tuberculosis (TB) and TB cases with AIDS. In: Program and abstracts of the International Conference on AIDS, June 1993. Abstract PO-B07-1166.
21. Small PM, Scheeler GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991;324:289-294.
22. Fischl MA, Daikos GL, Uttamchandani RB, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med. 1992;117:184-190.
23. Salomon N, Perlman DC, Freidmann P, Buchstein S, Kreiswirth BN, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis. 1995;21:1245-1252.